Diagnosis
Results 1 - 10 of 17
1 2 Next
By: Albert D. Min, MD
|
Join Albert D. Min, MD, as he discusses the treatment and management of chronic hepatitis B virus infection
Date Posted: 9/5/2008
|
 |
Download a HBV core curriculum slideset on the treatment and management of HBV for self study or use in your own presentations.
File Format: Microsoft PowerPoint (.ppt) | File Size: 1,358 KB
Date Posted: 9/5/2008
|
 |
File Format: Microsoft PowerPoint (.ppt) | File Size: 1,381 KB
Date Posted: 5/10/2006
|
By: Geoffrey M. Dusheiko, MD, FCP(SA), FRCP
|
Dr. Geoffrey Dusheiko reviews how measures of HBV DNA can be used to assess individual HBV-infected patients.
Date Posted: 4/19/2006
|
By: Gary L. Davis, MD, Jean-Michel Pawlotsky, MD, PhD, Mitchell L. Shiffman, MD
|
In this expert discussion, Drs. Davis, Pawlotsky, and Shiffman discuss the latest research on specific HCV inhibitors and other new drugs and provide insight and guidance about treatment of nonresponders to previous interferon-based therapy.
Date Posted: 2/9/2006
|
 |
File Format: Microsoft PowerPoint (.ppt) | File Size: 292 KB
Date Posted: 2/1/2006
|
By: Norah Terrault, MD, MPH, Paul Martin, MD, Robert J. Fontana, MD
|
In this expert discussion, Drs. Fontana, Martin, and Terrault provide perspective on presentations from the recent meeting.
Date Posted: 1/27/2006
|
By: Geoffrey M. Dusheiko, MD, FCP(SA), FRCP, Robert G. Gish, MD, Emmet B. Keeffe, MD, MACP, Robert P. Perrillo, MD
|
In this expert discussion, Drs. Dusheiko, Gish, Keeffe and Perrillo discuss the latest research on treatment and management of chronic hepatitis B.
Date Posted: 12/26/2005
|
|
Baseline serum ALT correlates poorly with liver biopsy scores.
Date Posted: 11/26/2005
|
 |
File Format: Microsoft PowerPoint (.ppt) | File Size: 142 KB
Date Posted: 11/11/2005
|
Results 1 - 10 of 17
1 2 Next
|
Featured Content
2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.
Join our experts as they review treatment options for patients with nonresponse to HCV therapy.
Expert faculty members review the most important advances in hepatitis and its mgmt in 2008.
|